Auckland Myeloma Patient Seminar, hosted by Myeloma New Zealand. We heard from Dr Henry Chan (Waitemata DHB), Dr Nicole Chien (Auckland DHB), Dr Ken Romeril and nursing staff from Auckland and North Shore Hospitals.Continue Reading

This article was originally posted by targeted Oncology Case: A 75-Year-Old Man with Multiple Myeloma Initial Presentation A 75-year-old man presents with worsening fatigue on exertion, pallor, and hip painPMH: osteoarthritisPE: tired appearing male, poor hand-grip strength, mild tenderness on palpation of the left hipECOG 2 Clinical workup Hb 9.8 g/dL, corrected calcium 11.9mg/dL, LDH 295U/L,...Continue Reading

This article was originally published on TheLimbic Australian experts have been ‘startled’ to discover that many patients with multiple myeloma do not receive recommended imaging and staging, sparking concerns about missed diagnoses and overtreatment of benign forms of the disease. The findings come from an analysis of real-world data of more than 2400 newly diagnosed...Continue Reading

Myeloma Australia’s Medical and Scientific Advisory Group (MSAG) presents the article of the week. On behalf of Myeloma Australia’s Medical and Scientific Advisory Group (MSAG) please find below our article of the week. 3-year follow up of the phase III CASTOR study with independent expert commentary provided by MSAG chair Professor H. Miles Prince AM (Research...Continue Reading

Welcome to issue 37 of Multiple Myeloma Research Review. This issue begins with a retrospective, multinational report describing the clinical features associated with outcomes of patients with MM who had acquired SARS-COV-2 infection. There is also research demonstrating that autologous HSCT is an important therapy among patients with MM, even our elderly patients. Researchers from...Continue Reading

Come along to our Auckland Myeloma Patient Seminar, hosted by Myeloma New Zealand.  We will hear from Dr Henry Chan (Waitemata DHB), Dr Nicole Chien (Auckland DHB), Dr Ken Romeril and nursing staff from Auckland and North Shore Hospitals.Continue Reading

This article was originally published on Cure While a diagnosis of multiple myeloma can be overwhelming for patients, the disease is very treatable, according to Dr. Andrew Yee. At CURE®’s Educated Patient® Summit on Multiple Myeloma, Yee, an assistant professor of medicine at Massachusetts General Hospital Cancer Center in Boston, discussed the signs and symptoms of...Continue Reading

This article was originally published on Wiley Online Library There are currently limited Australian data on the outcomes of autologous stem cell transplantation (ASCT) in elderly multiple myeloma (MM) patients. We present the largest cohort of elderly MM patients aged ≥65 years undergoing ASCT in Australia and report their outcomes based on our two‐centre experience. Our...Continue Reading

This article was originally posted on AJMC Multiple myeloma is not easily diagnosed, and its early symptoms may be confused for another condition. Each March, Multiple Myeloma Awareness Month puts multiple myeloma (MM) in the spotlight. A rare cancer, MM is not easily diagnosed early on, but it is the second most common blood cancer...Continue Reading

This article was originally published by Urbanhealth Today ABSTRACT BACKGROUND: The current standard of care for multiple myeloma requires several regimens of treatment, with patients experiencing high symptom burden and side effects, which negatively impact health-related quality of life (HRQoL). Thus, it is crucial to understand patient perceptions of multiple myeloma and how patients value...Continue Reading